Results 191 to 200 of about 713,469 (335)
SCF and TSLP expression are known to drive unique immune responses leading to the onset of allergic and inflammatory diseases. Here, we describe the characterization of a novel bsAb, CDX‐622, that targets SCF and TSLP. CDX‐622 inhibits MC functions through SCF starvation and Type 2 inflammatory responses via TSLP inhibition.
Michael B. Murphy +17 more
wiley +1 more source
Composite chronic lymphocytic leukemia and mantle cell lymphoma involving the bone marrow: a case report and literature review. [PDF]
Demianets R +9 more
europepmc +1 more source
PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia
Zhaohui Gu +59 more
semanticscholar +1 more source
This study analyzes molecular drivers of OIT responsiveness. Multi‐omics profiling of peanut‐stimulated PBMCs in a controlled peanut‐OIT trial identifies immune, transcriptomic, and epigenetic changes distinguishing complete responders from incomplete responders. Key findings highlight gastrointestinal immune mechanisms, including extracellular exosome
Aleix Arnau‐Soler +10 more
wiley +1 more source
Systemic CD3+ T-Cell Lymphoblastic Leukemia in a Bearded Dragon (<i>Pogona vitticeps)</i>: Clinical, Therapeutic, and Pathological Findings. [PDF]
Miljković J +10 more
europepmc +1 more source
HCVAD plus imatinib or dasatinib in lymphoid blastic phase chronic myeloid leukemia
P. Strati +13 more
semanticscholar +1 more source
Nutritional secondary hyperparathyroidism is a metabolic disorder caused by an imbalance in calcium homeostasis and is typically associated with the feeding of a calcium‐deficient diet. Nutritional secondary hyperparathyroidism has been reported in domestic species, including cats and dogs, as well as captive carnivores and wildlife including lions ...
JL Austen +5 more
wiley +1 more source
Proposed management of newly diagnosed Philadelphia chromosome‐positive (Ph+) acute lymphoblastic leukaemia (ALL) in transplant‐eligible patients. Suggested considerations when deciding the treatment pathway available to a newly diagnosed Ph+ ALL patient that would be deemed transplant eligible. Summary Acute lymphoblastic leukaemia (ALL) in 20%–30% of
Naranie Shanmuganathan, Andrew Grigg
wiley +1 more source
Mucocutaneous Manifestations of Leukemias and Lymphomas: A Clinical Study from a Tertiary Care Center in North India. [PDF]
Kaur I +3 more
europepmc +1 more source

